ENDNENZ3&Èÿÿÿÿ~N AB Abstract:AF Affiliation:'AN Accession Number: AN Accession Number: AU Author: (Review of: &) AU Author: CD CODEN:CL Classification:CP Country of Publication:DE Descriptors:DN Database Name:/DO DOI:+EA Email Address:'EI Electronic ISSN:EM Entry Month:ER Environmental Regime: FE Features:IS ISSN: LA Language:2 NT Notes:NU OT Original Title:.PT Publication Type:PY Publication Year:RN CAS Registry Number:RO Record Owner:SA  SF Subfile: SO Source:$ (), vol. , (), pp. , 20 SO Source:$ (), vol. , (), pp. , 19 SO Source: (), vol. , pp. , 20 SO Source: (), vol. , pp. , 19 SO Source:, vol. , (), pp. , 20 SO Source:, vol. , (), pp. , 19 SO Source:, vol. , pp. , 20 SO Source:, vol. , pp. , 19TC  TI Title: UD Update:ÃDD DDDby HD*ed. version. version [ ] edition. edition H DHD: DDDScale DDDSLSD L!L"L#L$L%L&L'DD DSDReport: L D, US DSpecial Issue: DHu‚‚‚ ‚ÿ ‚ ‚‚‚‚‚‚‚‚‚‚‚‚‚‚ SO Source: ‚™ CSA Z3950.csa.com&International Pharmaceutical Abstracts ipa-set-cF210 SUTRS Latin-1H?USERID1I ?PASSWORD1G000 â F Any Field*1016F Author*AUTH1003F Year*DATE31FTitle*4FKeywords*21FStandard Number*1007F All Fields*1035  HIntl Pharm Abs (CSA)CSALIMITATIONS 1. Source data in International Pharmaceutical Abstracts makes no distinction between issue and date; since dates are more common, both are imported into the Date field. Users may need to manually move the issue into the Issue field after importing.DCambridge Scientific Abstracts